• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PNAS: Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo

tetano

Editor, Senior Moderator
[h=1]Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo[/h] Louisa E. Sjaastad, Elizabeth J. Fay, Jessica K. Fiege, Marissa G. Macchietto, Ian A. Stone, Matthew W. Markman, Steven Shen, and Ryan A. Langlois
PNAS September 18, 2018 115 (38) 9610-9615; published ahead of print September 4, 2018 https://doi.org/10.1073/pnas.1807516115
Add to Cart ($10)
  • Edited by Michael B. A. Oldstone, The Scripps Research Institute, La Jolla, CA, and approved August 8, 2018 (received for review May 9, 2018)
    [h=2]Significance[/h] Influenza A virus has a broad cellular tropism in the respiratory tract. Infected epithelial cells sense the infection and initiate an antiviral response. Here, we used single-cycle replication reporter viruses to analyze the early cellular response to influenza infection in vivo. This approach revealed distinct tiers of antiviral responses that were associated with the magnitude of virus replication. We also unveiled disparate protection of epithelial cell types mediated by interferon during virus spread. These results demonstrate the early landscape of virus?host interactions in vivo with the magnitude and round of replication revealing distinct antiviral signatures and responses.

    [h=2]Abstract[/h] Influenza virus has a broad cellular tropism in the respiratory tract. Infected epithelial cells sense the infection and initiate an antiviral response. To define the antiviral response at the earliest stages of infection we used a series of single-cycle reporter viruses. These viral probes demonstrated cells in vivo harbor a range in magnitude of virus replication. Transcriptional profiling of cells supporting different levels of replication revealed tiers of IFN-stimulated gene expression. Uninfected cells and cells with blunted replication expressed a distinct and potentially protective antiviral signature, while cells with high replication expressed a unique reserve set of antiviral genes. Finally, we used these single-cycle reporter viruses to determine the antiviral landscape during virus spread, which unveiled disparate protection of epithelial cell subsets mediated by IFN in vivo. Together these results highlight the complexity of virus?host interactions within the infected lung and suggest that magnitude and round of replication tune the antiviral response.

    http://www.pnas.org/content/115/38/9610
 
Back
Top Bottom